EUVIMEDDécouvrir EUVIMED
Open access · CC BY 4.0

Platform development for high‐throughput optimization of perfusion processes: Part I: Implementation of cell bleeds in microwell plates

Marie Dorn, Kerensa Klottrup-Rees, Ken Lee, Martina Micheletti

Biotechnology and Bioengineering · 2024

DOI: 10.1002/bit.28682 ↗

At a glance

Journal article in Biotechnology and Bioengineering, 2024. Written by Marie Dorn and 3 co-authors. Institution: Department of Biochemical Engineering, Advanced Centre for Biochemical Engineering, University College London, London, UK. Major MEDLINE topics: Cricetulus, High-Throughput Screening Assays. Cited 8 times so far (Crossref); 29 references. The full text is freely available (open access, CC BY 4.0). Funded by: AstraZeneca, Engineering and Physical Sciences Research Council.

RésuméSubjectsRéférences bibliographiquesCiteRelated studies

Abstract (original language)

The promise of continuous processing to increase yields and improve product quality of biopharmaceuticals while decreasing the manufacturing footprint is transformative. Developing and optimizing perfusion operations requires screening various parameters, which is expensive and time‐consuming when using benchtop bioreactors. Scale‐down models (SDMs) are the most feasible option for high‐throughput data generation and condition screening. However, new SDMs mimicking perfusion are required, enabling experiments to be run in parallel. In this study, a method using microwell plates (MWP) operating in semi‐perfusion mode with an implemented cell bleed step is presented. A CHO cell line was cultivated in a 24‐well MWP (V w = 1.2 mL) and grown at four high cell density (HCD) setpoints. Quasi steady‐state condition was obtained by manually performing cell bleeds followed by a total medium exchange after centrifugation. Further, two HCD setpoints were scaled up (V W = 30 mL), comparing a squared six‐well deepwell plate (DWP) to shake flasks (SF). This evaluation showed comparable results between systems (DWP vs. SF) and scales (MWP vs. DWP + SF). The results show that the well‐plate‐based methods are suitable to perform HCD and quasi steady‐state cultivations providing a robust solution to industrially relevant challenges such as cell clone and media selection.

Subjects

MeSH terms (MEDLINE)

CricetulusHigh-Throughput Screening AssaysCHO CellsAnimalsBioreactorsCell Culture TechniquesCell Count

Author keywords

deepwell platehigh‐throughputmicrowell plateperfusionprocess developmentsmall‐scale

Authors and institutions

  • Department of Biochemical Engineering, Advanced Centre for Biochemical Engineering, University College London, London, UK.
  • Cell Culture and Fermentation Sciences, Biopharmaceutical Development, AstraZeneca, Cambridge, UK.
  • BioProcess Technologies and Engineering, Biopharmaceutical Development, AstraZeneca, Gaithersburg, Maryland, USA.

Funding

  • AstraZeneca
  • Engineering and Physical Sciences Research Council

Cite

APA

Dorn, M., Klottrup-Rees, K., Lee, K., & Micheletti, M. (2024). Platform development for high‐throughput optimization of perfusion processes: Part I: Implementation of cell bleeds in microwell plates. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28682

Vancouver

Dorn M, Klottrup-Rees K, Lee K, Micheletti M. Platform development for high‐throughput optimization of perfusion processes: Part I: Implementation of cell bleeds in microwell plates. Biotechnology and Bioengineering. 2024. doi:10.1002/bit.28682

BibTeX
@article{Dorn2024,
  author = {Dorn, Marie and Klottrup-Rees, Kerensa and Lee, Ken and Micheletti, Martina},
  title = {Platform development for high‐throughput optimization of perfusion processes: Part I: Implementation of cell bleeds in microwell plates},
  journal = {Biotechnology and Bioengineering},
  year = {2024},
  doi = {10.1002/bit.28682}
}
Start for free →